Showing results (61-70 of 134) with videos related to
Sort By:
Pageof 14
Biomedicines|November 11, 2022
New Insights into Molecular Mechanisms of Chronic Kidney DiseaseWeronika Frąk, Joanna Kućmierz, Magdalena Szlagor, et al.Biomedicines|September 28, 2021
Is a High HDL-Cholesterol Level Always Beneficial?Beata Franczyk, Jacek Rysz, Janusz Ławiński, et al.International Journal of Molecular Sciences|April 3, 2021
Diabetes and Cardiovascular Risk in Renal Transplant PatientsJacek Rysz, Beata Franczyk, Maciej Radek, et al.Biomedicines|September 28, 2023
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney DiseaseAnna Gluba-Sagr, Beata Franczyk, Magdalena Rysz-Górzyńska, et al.Current Vascular Pharmacology|January 26, 2012
Acute coronary syndromes in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.BMC Nephrology|December 5, 2012
Prevention of sudden cardiac death in patients with chronic kidney diseaseBeata Franczyk-Skóra, Anna Gluba, Maciej Banach, et al.Current Vascular Pharmacology|June 2, 2018
Cholesterol Subfraction Analysis in Patients with Acute Coronary SyndromeMichal Kidawa, Anna Gluba-Brzózka, Marzenna Zielinska, et al.Current Vascular Pharmacology|October 25, 2016
Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) PatientsAnna Gluba-Brzozka, Beata Franczyk, Piotr Bartnicki, et al.Expert Opinion on Pharmacotherapy|October 9, 2018
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy?Beata Franczyk, Anna Gluba-Brzózka, Łukasz Jurkiewicz, et al.Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?Beata Franczyk, Jacek Rysz, Jarosław Miłoński, et al.Pageof 14